A Phase Ib Study of the combination of Aurora Kinase Inhibitor alisertib (MLN8237) and bortezomib in Relapsed or Refractory Multiple Myeloma

Saved in:
Bibliographic Details
Published in:British journal of haematology 2015-09, Vol.174 (2), p.323-325
Main Authors: Rosenthal, Allison, Kumar, Shaji, Hofmeister, Craig, Laubach, Jacob, Vij, Ravi, Dueck, Amylou, Gano, Katherine, Stewart, A. Keith
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.13765